High expression of DNMT3B negatively impacts on clinical outcome of older patients (pts) with primary cytogenetically normal (CN) acute myeloid leukemia (AML) [CALGB 20202 (Alliance)].
   Google Scholar   
Citation:
European Hematology Association Congress abstr S1168
Meeting Instance:
EHA 2013
Year:
2013
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
2187  
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
                                           
Networks:
 
Study
CALGB-20202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
N/A
Keywords: